CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
暂无分享,去创建一个
A. Carbone | G. Parmiani | N. Lazar | M. Daniotti | B. Perbal | M. Rodolfo | L. Rivoltini | A. Balsari | G. Tragni | Paola Deho | F. Ratti | V. Vallacchi | A. De Filippo | Delia Di Stasi
[1] A. Llombart‐Bosch,et al. Domain-specific CCN3 antibodies as unique tools for structural and functional studies , 2007, Journal of Cell Communication and Signaling.
[2] A. Ori,et al. Antiproliferative activity of CCN3: Involvement of the C‐terminal module and post‐translational regulation , 2007, Journal of cellular biochemistry.
[3] T. Enver,et al. NOV (CCN3) Functions as a Regulator of Human Hematopoietic Stem or Progenitor Cells , 2007, Science.
[4] N. Hayward,et al. Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. , 2007, Cancer research.
[5] Andrew Leask,et al. All in the CCN family: essential matricellular signaling modulators emerge from the bunker , 2006, Journal of Cell Science.
[6] M. Herlyn,et al. CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1 , 2006, The Journal of cell biology.
[7] Adam Byron,et al. Integrin ligands at a glance , 2006, Journal of Cell Science.
[8] A. Whetton,et al. A novel mechanism for BCR-ABL action: stimulated secretion of CCN3 is involved in growth and differentiation regulation. , 2006, Blood.
[9] S. Saule,et al. Nuclear addressing provides a clue for the transforming activity of amino‐truncated CCN3 proteins , 2006, Journal of cellular biochemistry.
[10] D. Schadendorf,et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. , 2006, Pigment cell research.
[11] N. Chegini,et al. CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-beta and regulation by TGF-beta in leiomyoma and myometrial smooth muscle cells. , 2006, Molecular human reproduction.
[12] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[13] M. Herlyn,et al. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. , 2005, The journal of investigative dermatology. Symposium proceedings.
[14] M. Colombo,et al. In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type , 2005, Oncogene.
[15] M. Takigawa,et al. CCN Proteins: A New Family of Cell Growth And Differentiation Regulators , 2005 .
[16] A. Bosserhoff,et al. Integrin signaling in malignant melanoma , 2005, Cancer and Metastasis Reviews.
[17] M. Takigawa,et al. THE CCN FAMILY OF PROTEINS: AN OVERVIEW , 2005 .
[18] L. Lau,et al. Integrin-dependent Functions of the Angiogenic Inducer NOV (CCN3) , 2005, Journal of Biological Chemistry.
[19] M. Laurent,et al. NOV/CCN3 Induces Adhesion of Muscle Skeletal Cells and Cooperates with FGF2 and IGF-1 to Promote Proliferation and Survival , 2005, Cell communication & adhesion.
[20] M. Daniotti,et al. Genetic progression of metastatic melanoma. , 2004, Cancer letters.
[21] H. Yeger,et al. Potential cellular conformations of the CCN3(NOV) protein , 2004, Cell Communication and Signaling.
[22] M. Pierotti,et al. BRAF alterations are associated with complex mutational profiles in malignant melanoma , 2004, Oncogene.
[23] B. Perbal. CCN proteins: multifunctional signalling regulators , 2004, The Lancet.
[24] H. Kleinman,et al. NOVH increases MMP3 expression and cell migration in glioblastoma cells via a PDGFR‐α‐dependent mechanism , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] N. Planque,et al. A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis , 2003, Cancer Cell International.
[26] L. Lau,et al. CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family* , 2003, Journal of Biological Chemistry.
[27] M. Hyvönen,et al. Adhesion of Endothelial Cells to NOV Is Mediated by the Integrins αvβ3 and α5β1 , 2003, Journal of Vascular Research.
[28] F. Lallemand,et al. The Expression of novH in Adrenocortical Cells Is Down-regulated by TGFβ1 through c-Jun in a Smad-independent Manner* , 2002, The Journal of Biological Chemistry.
[29] Arnoud Sonnenberg,et al. Function and interactions of integrins , 2001, Cell and Tissue Research.
[30] B. Perbal. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues , 2001, Molecular pathology : MP.
[31] Qin Chen,et al. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[32] L. Lau,et al. The CCN family of angiogenic regulators: the integrin connection. , 1999, Experimental cell research.
[33] P. Schofield,et al. novH: differential expression in developing kidney and Wilm's tumors. , 1998, The American journal of pathology.
[34] K. von der Mark,et al. Specific Induction of Cell Motility on Laminin by 7 Integrin (*) , 1996, The Journal of Biological Chemistry.
[35] V. Joliot,et al. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas , 1992, Molecular and cellular biology.
[36] R. Timpl,et al. Laminin-binding integrin alpha 7 beta 1: functional characterization and expression in normal and malignant melanocytes. , 1991, Cell regulation.
[37] R. Kramer,et al. Human melanoma cells express a novel integrin receptor for laminin. , 1989, The Journal of biological chemistry.
[38] B. Perbal. The CCN3 protein and cancer. , 2006, Advances in experimental medicine and biology.
[39] M. Ginsberg,et al. Integrin regulation. , 2005, Current opinion in cell biology.
[40] Judith P. Johnson. Cell Adhesion Molecules in the Development and Progression of Malignant Melanoma , 2004, Cancer and Metastasis Reviews.
[41] D. Brewster,et al. Trends in cancer incidence and mortality in Scotland: description and possible explanations. , 1998, British Journal of Cancer.
[42] N. J. McNally,et al. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). , 1998, British Journal of Cancer.
[43] R. Timpl,et al. Laminin-binding integrin α7β1 : functional characterization and expression in normal and malignant melanocytes , 1991 .